-
Product Insights
B-Cell Chronic Lymphocytic Leukemia - Drugs In Development, 2024
Empower your strategies with our B-Cell Chronic Lymphocytic Leukemia – Drugs In Development, 2024 report and make more profitable business decisions. B-cell chronic lymphocytic leukemia is a type of slow-growing leukemia that affects developing B-lymphocytes (also known as B-cells). Symptoms include swollen lymph nodes (glands) in the neck, under the arms, or in the groin; pain or discomfort under the ribs on the left side due to an enlarged spleen; frequent or repeated infections and slow healing, due to a lack...
-
Product Insights
Ependymoma - Drugs In Development, 2024
Empower your strategies with our Ependymoma – Drugs In Development, 2024 report and make more profitable business decisions. Ependymoma is a type of glioma that develops from ependymal cells. Ependymomas usually develop in the lining of the ventricles or in the spinal cord. The most common place they are found in children is near the cerebellum. The tumor often blocks the flow of cerebral spinal fluid (CSF), causing increased intracranial pressure. Ependymomas are often slow-growing tumours, and any signs and symptoms...
-
Product Insights
Hairy Cell Leukemia - Drugs In Development, 2024
Empower your strategies with our Hairy Cell Leukemia – Drugs In Development, 2024 report and make more profitable business decisions. Hairy cell leukemia is a rare, slow-growing cancer of the blood in which bone marrow makes too many B cells (lymphocytes), a type of white blood cell that fights infection. Symptoms include fatigue, easy bruising, recurring infections, weakness, and weight loss. Risk factors include exposure to radiation, chemicals, and saw dust. Treatment includes surgery, chemotherapy, and radiation therapy. The Hairy Cell...
-
Product Insights
Testicular Cancer - Drugs In Development, 2024
Empower your strategies with our Testicular Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Testicular cancer stands out as a prevalent malignancy affecting men in the age group of 15 to 45 years. Its etiology is complex, involving a combination of genetic and environmental factors. Advancements in understanding the epidemiology, pathophysiology, and diagnostic approaches have paved the way for sophisticated management strategies. Notably, the prognosis for testicular cancer has significantly improved, boasting cure rates reaching up...
-
Product Insights
Biliary Tumor - Drugs In Development, 2024
Empower your strategies with our Biliary Tumor – Drugs In Development, 2024 report and make more profitable business decisions. Bile duct cancer, or cholangiocarcinoma, is a rare malignancy arising from malignant cells forming in the bile ducts. It presents in two main types: intrahepatic, occurring inside the liver, and extrahepatic, forming outside the liver. Extrahepatic bile duct cancer further divides into perihilar, found where the right and left bile ducts meet, and distal, located where liver and gallbladder ducts merge. Symptoms...
-
Product Insights
Squamous Non-Small Cell Lung Carcinoma - Drugs In Development, 2024
Empower your strategies with our Squamous Non-Small Cell Lung Carcinoma – Drugs In Development, 2024 report and make more profitable business decisions. Squamous cell carcinoma (SCC) of the lung, a subtype of non-small cell lung cancer (NSCLC), typically arises centrally in the main airways like the bronchi. This cancer variant is predominantly linked to tobacco smoke, being the primary cause of cellular transformation. Smoking accounts for about 80% of lung cancer cases in men and 90% in women, with SCC showing...
-
Product Insights
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) - Drugs In Development, 2024
Empower your strategies with our Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) – Drugs In Development, 2024 report and make more profitable business decisions. Leptomeningeal carcinomatosis is a condition involving the infiltration of cancer into the protective layers of the brain, specifically the pia mater and arachnoid mater. Solid tumors, notably breast, lung, melanoma, gastrointestinal, and primary central nervous system tumors, can give rise to leptomeningeal carcinomatosis. Cancer cells may reach the leptomeninges through various routes, such as direct seeding from brain...
-
Product Insights
Malignant Fibrous Histiocytoma - Drugs In Development, 2024
Empower your strategies with our Malignant Fibrous Histiocytoma – Drugs In Development, 2024 report and make more profitable business decisions. Malignant fibrous histiocytoma, now termed undifferentiated pleomorphic sarcoma (UPS), is thought to originate from primitive mesenchymal cells, emerging in soft tissue or bone, typically in the extremities or retroperitoneum. Most common in late adulthood, it exhibits a slight male predominance, constituting the most prevalent soft tissue sarcoma. The subtypes include storiform/pleomorphic, myxoid, giant cell, inflammatory, and angiomatoid. Diagnostic imaging, such as...
-
Product Insights
Malignant Neoplasms - Drugs In Development, 2024
Empower your strategies with our Malignant Neoplasms – Drugs In Development, 2024 report and make more profitable business decisions. A tumor is a mass comprising atypical neoplastic cells, frequently exhibiting pleomorphism and the capability to invade surrounding tissues. Malignant neoplasms possess the characteristic of metastasizing to distant anatomical sites and may recur even after surgical excision. Among the most prevalent types of malignant neoplasms are carcinomas, which arise from epithelial tissues, Hodgkin and non-Hodgkin lymphomas originating in the lymphatic system, leukemias...
-
Product Insights
Oligodendroglioma - Drugs In Development, 2024
Empower your strategies with our Oligodendroglioma – Drugs In Development, 2024 report and make more profitable business decisions. Oligodendroglioma is a type of glioma (primary glial brain tumor). They often contain mineral deposits (called calcifications), areas of hemorrhage, and/or cysts. The most common symptoms are seizures, headaches, and personality changes. Other symptoms vary by location and size of the tumor. Treatment includes chemotherapy surgery and radiation therapy. The Oligodendroglioma drugs in development market research report provide comprehensive information on the therapeutics...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.